×

Our team

Hexagon Bio’s diverse team combines computational biology and experimental investigation, with deep expertise at the intersection of these fields.

Leadership

Maureen Hillenmeyer, PhD

CEO & Founder

Maureen is a founder and CEO of Hexagon Bio. Previously, she was director of the Genomes to Natural Products program and group leader at the Stanford Technology Genome Center.

Brian Naughton, PhD

Head of Data & Founder

Brian is a founder and head of data at Hexagon Bio. Previously, he was founding scientist at 23andMe.

Yi Tang, PhD

Founder

Yi is a founder of Hexagon Bio, Professor at UCLA, and a world expert on fungal enzymes and natural products.

Colin Harvey, PhD

Head of Biology & Chemistry & Founder

Colin is a founder and Head of Chemistry and Biology at Hexagon Bio. Previously, he led synthetic biology efforts for natural product discovery at the Stanford Genome Technology Center.

Andy Aymeloglu

Head of Engineering

Andy is the Head of Engineering at Hexagon Bio. Previously he was Director of Engineering at Palantir Technologies.

Tod Smeal, PhD

Chief Scientific Officer

Tod leads Hexagon Bio's drug discovery team. Previously, he was Chief Scientific Officer of Cancer Biology at Lilly Research Labs. Tod has led many oncology programs at Lilly, Pfizer, and SUGEN where he played key roles on lorlatinib, crizotinib, and nirogacestat.

→ Meet our team on LinkedIn.

Board of Directors

David Goeddel, PhD

Managing Partner, The Column Group

Chairman, Hexagon Bio

Maureen Hillenmeyer, PhD

CEO & Founder, Hexagon Bio

Brian Naughton, PhD

Head of Data & Founder, Hexagon Bio

Millie Ray, PhD

Principal, The Column Group

Alex Kolicich

Founding Partner, 8VC

Juan Jaen, PhD

President & Co-Founder, Arcus Biosciences

Investors

Hexagon Bio

1505 Adams Drive, Suite A
Menlo Park, CA 94025
info@hexagonbio.com